Eiko Lifesciences Ltd (BSE: 540204) is a Thane, Maharashtra-based company in the Pharmaceutical Intermediates industry. With a market capitalisation of ₹70 Cr, it ranks #3,573 by market cap among the 6,137 Indian listed companies on FinBizNet, and #3 of 4 in Pharmaceutical Intermediates. At ₹50.79 (as of 25 Oct 2026), the share price is 21.2% below its 52-week high of ₹64.44 and 18.1% above its 52-week low of ₹43.00. The share price is up 0.6% over one year and up 3.8% over three months.
| Current Price | ₹50.79 |
|---|---|
| Market Cap | ₹70 Cr |
| BSE Code | 540204 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Pharmaceutical Intermediates |
| P/E Ratio | 16.3 |
| Return on Equity | 8.40% |
| Return on Assets | 5.05% |
| 52-Week Range | ₹43.00 – ₹64.44 |
| 1-Year Price Change | +0.6% |
| 3-Month Price Change | +3.8% |
| Beta (1Y) | 0.36 |
| Dividend Yield | 0.00% |
| Headquarters | Thane, Maharashtra |
| Website | eikolifesciences.com |
Eiko LifeSciences Limited, together with its subsidiary, manufactures and sells specialty and fine chemicals in India and internationally. It operates through Agrochemicals; Oleo Chemicals; Pharmaceuticals; Food Additives; Clinical Research, Development; and Logistics segments. It also offers cosmetic emollients, and flavor and fragrances. In addition, the company is involved in manufacturing, suppling, and exporting of specialty chemicals, fine chemicals, and pharma intermediates; acquiring, manufacturing, leasing, and renting, and managing shipping containers; and clinical research, development, and innovation within the specialty chemicals, healthcare, and other medical fields. Its products are used in pharmaceuticals, agrochemicals, aroma chemicals, consumer goods, and electronic chemicals. The company also export its products. The company was formerly known as Narendra Investments (Delhi) Limited and changed its name to Eiko LifeSciences Limited in June 2021. Eiko LifeSciences Lim
1. Asset Management-This segment offers asset management services.
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| DCM Shriram Fine Chemicals Limited | ₹236 Cr | -65.2 | -1.67% | ₹91 Cr | — |
| Samrat Pharmachem Ltd. | ₹79 Cr | -24.8 | -4.73% | ₹80 Cr | -4.1% |
| Eiko Lifesciences Ltd | ₹70 Cr | 16.3 | 8.40% | — | +0.6% |
| Caprolactam Chemicals Ltd. | ₹22 Cr | 12.4 | 30.87% | ₹0 Cr | +12.3% |
Listed by market capitalisation. Ratios are shown for context only.
Eiko Lifesciences Ltd is trading at ₹50.79, with a market capitalisation of ₹70 Cr.
Eiko Lifesciences Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Pharmaceutical Intermediates).
Eiko Lifesciences Ltd has a P/E of 16.3 and a return on equity of 8.40%.
Eiko Lifesciences Ltd is listed on the BSE under the scrip code 540204.
Eiko Lifesciences Ltd's share price is up 0.6% over one year and up 3.8% over three months. Its 52-week range is ₹43.00 to ₹64.44.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.